XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Operating activities:    
Net income $ 71,257 $ 83,101
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Impairment of Real Estate 43,785 4,351
Impairment Losses Related to Real Estate Partnerships 0 647
Loss on sale of real estate 1,135 0
Gain on Insurance Recovery 0 (552)
Deferred income tax benefit (182) 0
Equity in loss from joint ventures (2,600) 1,315
Proceeds from Equity Method Investment, Distribution 0 780
Financing Receivable, Credit Loss, Expense (Reversal) 312 9,206
Depreciation and amortization 84,909 80,810
Amortization of deferred financing costs 4,279 4,161
Amortization of above/below market leases and tenant allowances, net (274) (176)
Share-based Payment Arrangement, Noncash Expense 8,799 8,414
share based compensation included in severance expense 304 0
Increase (Decrease) in Operating Lease Assets and Liabilities, Net 460 (100)
Mortgage notes accrued interest receivable (917) 350
Accounts receivable 249 22,168
Other assets (6,181) (3,902)
Accounts payable and accrued liabilities 5,466 2,955
Increase (Decrease) in Deferred Revenue 4,887 6,152
Net cash provided by operating activities 220,888 217,050
Investing activities:    
Payments to Acquire Productive Assets 47,115 169,656
Proceeds from Sale of Productive Assets 8,373 80
Payments to Acquire Interest in Subsidiaries and Affiliates (3,399) (17,843)
Proceeds from Equity Method Investment, Distribution, Return of Capital 0 6,695
Payments for Derivative Instrument, Investing Activities 0 (3,830)
Investment in mortgage notes receivable (6,040) (11,305)
Proceeds from Sale and Collection of Mortgage Notes Receivable 268 272
Investment in promissory notes receivable 3,025 0
Proceeds from promissory note receivable paydown 353 189
Proceeds from Insurance Recovery 0 1,071
Additions to properties under development (38,886) (9,393)
Net cash used by investing activities (89,471) (203,720)
Financing activities:    
Deferred financing fees paid (279) (328)
Net proceeds from issuance of common shares 311 359
Payment, Tax Withholding, Share-based Payment Arrangement 0 (4)
Purchase of common shares for treasury (3,662) (4,250)
Dividends paid to shareholders (136,057) (129,968)
Net cash used by financing activities (139,687) (134,191)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93 503
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (8,177) (120,358)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 102,334 169,543
Cash and Cash Equivalents, at Carrying Value 99,711 168,266
Restricted Cash and Cash Equivalents 2,623 1,277
Supplemental schedule of non-cash activity:    
Transfer of property under development to rental property 29,366 38,119
Real Estate Owned, Transfer from Real Estate Owned 1,321 0
Issuance of nonvested shares and restricted share units at fair value, including nonvested shares issued for payment of bonuses 25,805 21,751
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability 0 29,022
Supplemental disclosure of cash flow information:    
Interest Paid, Excluding Capitalized Interest, Operating Activities 63,417 63,551
Cash paid during the period for income taxes 964 657
Interest cost capitalized 1,629 271
Change in accrued capital expenditures $ (5,639) $ (217)